What does MORPHEUS MEDICAL do?

MORPHEUS MEDICAL is a specialist medical practice in Waterloo. Private Limited, started on 19 July 2022, 1 establishment.

What is the address of MORPHEUS MEDICAL?

The registered office of MORPHEUS MEDICAL is located at Drève des Chasseurs 2, 1410 Waterloo.

Is MORPHEUS MEDICAL still active?

Yes. According to the CBE (30 September 2026) MORPHEUS MEDICAL is active, legal situation “Normale toestand”, started on 19 July 2022.

Is MORPHEUS MEDICAL registered on Peppol?

Yes, MORPHEUS MEDICAL is registered on the Peppol network with ID 0208:0788722539.

What is the enterprise number of MORPHEUS MEDICAL?

The enterprise number of MORPHEUS MEDICAL is BE0788722539.

When was MORPHEUS MEDICAL founded?

MORPHEUS MEDICAL was founded on 19 July 2022.

Who are the directors of MORPHEUS MEDICAL?

According to the 2024 annual accounts, the directors of MORPHEUS MEDICAL are: Miriam JANIN.

Is MORPHEUS MEDICAL a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 19 July 2022; 3 annual accounts filed, latest fiscal year 2024; 1 directors known from the annual account.

How much profit did MORPHEUS MEDICAL make in 2024?

MORPHEUS MEDICAL posted a profit after taxes of € 105,824 in financial year 2024.

What is the revenue of MORPHEUS MEDICAL?

As a small company, MORPHEUS MEDICAL is not required to publish revenue in its annual accounts. In financial year 2024, its added value was € 175,912.

MORPHEUS MEDICAL (Private Limited) - Waterloo

Dossier MORPHEUS MEDICAL, printed on 30 September 2026 from databakkes.be/en/0788722539/morpheus-medical. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2024

MORPHEUS MEDICAL from Waterloo, company number BE0788722539, closed financial year 2024 with a result of € 105,824 after tax. For that financial year MORPHEUS MEDICAL recorded a gross margin of € 175,912 and equity of € 466,230. Compared with financial year 2023, the result moved from € 93,170 to € 105,824. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 27, 2025.

What it is worth Growing

€ 466,230

▲ 29% vs 2023

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 105,824

▲ 14% vs 2023

Profit after tax over the fiscal year.

Cash in the bank

€ 135,955

▲ 47% vs 2023

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2024. Retained profit grew to € 463,730.

People and assets in 2024

Vehicles and equipment

€ 1,972

▼ 77% vs 2023

Book value of vehicles, furniture and equipment.

Debts at end 2024

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 504

▲ € 467 vs 2023

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 10,800

▼ 55% vs 2023

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	Change 2023 → 2024
Gross margin	€ 351,409 Gross margin 2022: € 351,409 First fiscal year in the series	€ 119,215 Gross margin 2023: € 119,215 ▼ 66% vs 2022 (€ 351,409) Unfavourable step	€ 175,912 Gross margin 2024: € 175,912 ▲ 48% vs 2023 (€ 119,215) Favourable step	▲ 48%
Profit after taxes	€ 264,737 Profit after taxes 2022: € 264,737 First fiscal year in the series	€ 93,170 Profit after taxes 2023: € 93,170 ▼ 65% vs 2022 (€ 264,737) Unfavourable step	€ 105,824 Profit after taxes 2024: € 105,824 ▲ 14% vs 2023 (€ 93,170) Favourable step	▲ 14%
Equity	€ 267,237 Equity 2022: € 267,237 First fiscal year in the series	€ 360,406 Equity 2023: € 360,406 ▲ 35% vs 2022 (€ 267,237) Favourable step	€ 466,230 Equity 2024: € 466,230 ▲ 29% vs 2023 (€ 360,406) Favourable step	▲ 29%
Total debts	€ 83,053 Total debts 2022: € 83,053 First fiscal year in the series	€ 24,237 Total debts 2023: € 24,237 ▼ 71% vs 2022 (€ 83,053) Favourable step	€ 11,304 Total debts 2024: € 11,304 ▼ 53% vs 2023 (€ 24,237) Favourable step	▼ 53%
Cash	€ 31,001 Cash 2022: € 31,001 First fiscal year in the series	€ 92,470 Cash 2023: € 92,470 ▲ 198% vs 2022 (€ 31,001) Favourable step	€ 135,955 Cash 2024: € 135,955 ▲ 47% vs 2023 (€ 92,470) Favourable step	▲ 47%
Retained profit	€ 264,737 Retained profit 2022: € 264,737 First fiscal year in the series	€ 357,906 Retained profit 2023: € 357,906 ▲ 35% vs 2022 (€ 264,737) Favourable step	€ 463,730 Retained profit 2024: € 463,730 ▲ 30% vs 2023 (€ 357,906) Favourable step	▲ 30%
Balance sheet total	€ 350,289 Balance sheet total 2022: € 350,289 First fiscal year in the series	€ 384,643 Balance sheet total 2023: € 384,643 ▲ 10% vs 2022 (€ 350,289) Unchanged	€ 477,534 Balance sheet total 2024: € 477,534 ▲ 24% vs 2023 (€ 384,643) Unchanged	▲ 24%

Key figures of MORPHEUS MEDICAL, fiscal years 2022 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.

What happened to MORPHEUS MEDICAL?

What happened at MORPHEUS MEDICAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 27, 2025 New annual accounts for financial year 2024: profit of € 105,824 (▲ 14% vs 2023). filed late Source: NBB ↗
Jul 19, 2022 New establishment in Waterloo. KBO
Jul 19, 2022 Start of the company according to the CBE. KBO

In short

From € 264,737 profit in 2022 to € 105,824 profit in 2024.

Paid € 140,047 in corporate taxes since 2022.

Best year ever: 2022, with € 264,737 profit.

Original PDFs at the National Bank ↗

A new publication or filing at MORPHEUS MEDICAL? We notify you, reason included.

Follow MORPHEUS MEDICAL

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Miriam JANIN

MORPHEUS MEDICAL

Behind MORPHEUS MEDICAL is Miriam JANIN.

See the full network in the app

Directors

According to the 2024 annual accounts

Miriam JANIN

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Drève des Chasseurs 2

1410 Waterloo

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0788.722.539
VAT number: BE 0788.722.539
Registered office: Drève des Chasseurs 2, 1410 Waterloo
Names & denominations: MORPHEUS MEDICAL
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 19 July 2022
Peppol: Active · Active since 8 Dec 2025
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗